USPTO serial 99420282
LAYAR
Reviewed by CopyMark Law Group
Status 730Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- CHISOLM, KEVON
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with LAYAR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*
Plus Government fees of $300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Carrie Webb Olson
Carrie Webb Olson Day Pitney LLPOne Federal Street - 29th FloorBoston, MA 02110United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software to assist with product development, data analysis, and management in the field of pharmaceuticals, pharmacometrics and drug research; Downloadable computer software for transmitting, analyzing and generating reports; Downloadable computer software for data processing and analysis in the fields of pharmaceuticals, pharmacometrics and drug research; Downloadable computer software for research with dashboard functionality providing grid and graphical visualizations of formatted data allowing users to analyze and visually identify relationships among histopathology, clinical chemistry, and hematology findings in the field of pharmaceutical development; Downloadable computer software in the field of pharmaceutical development facilitating simultaneous analysis of formatted data from multiple studies, data querying, mining and visualization for pharmaceutical research and development using formatted data files as data sources; Downloadable computer software for drug development research; Downloadable software for use in analyzing and integrating biomedical, pharmaceutical, and clinical data; Downloadable software using artificial intelligence and machine learning for predictive modeling, data mining, semantic search, and natural language processing in the fields of drug discovery, development, and regulatory submissions | ACTIVE | — |
| 042 | Scientific research, namely, chemical, biochemical, and molecular analysis, research and testing services in the pharmaceutical, pharmacometrics, drug research, biotechnology and agrochemical industries, and the development and testing of new pharmaceutical products for others; Design of customized cheminformatics software for others; Consultation in the field of computer software and computer hardware design for others; Technological consultation in the field of computer networking; Software as a service (SAAS) services featuring software for data integration; Software as a service (SAAS) services featuring software for creating a network of disparate data; Software as a service (SAAS) services featuring software using artificial intelligence for data integration; Providing online non-downloadable software for data integration; Providing online non-downloadable software for creating networks of disparate data; Providing online non-downloadable software using artificial intelligence for data integration; Providing temporary use of non-downloadable computer software for integrating various databases in the fields of pharmaceuticals, pharmacometrics, drug research and logical data modeling; Providing temporary use of non-downloadable software for the collection, tracking, editing, organizing, analyzing, transmission, storage and sharing of data and information; Platform as a service (PAAS) featuring computer software platforms for predictive data analytics, data modeling and analytics; Providing online non-downloadable software for data input, integration and analytics in the fields of pharmaceuticals, pharmacometrics and drug research; Consultancy in the fields of information technology, pharmacology and software design; Software as a service (SAAS) featuring software for integrating and analyzing structured and unstructured biomedical data using artificial intelligence and machine learning; Providing temporary use of non-downloadable software for semantic search, predictive modeling, and natural language processing in the pharmaceutical, biotechnology, and healthcare industries; Platform as a service (PAAS) featuring computer software platforms for data visualization, data integration, and decision support in pharmaceutical research and development | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 11, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 10, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 10, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 10, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 24, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 30, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 30, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 24, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 2, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 1, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 30, 2025 | ALIE | ASSIGNED TO LIE | — |
| Nov 25, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 25, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 25, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 24, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 2, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 30, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 30, 2025 | NWAP | NEW APPLICATION ENTERED | — |